Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. (NUS) Stock Competitors & Peer Comparison
See (NUS) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NUS | $8.66 | -0.57% | 412.7M | 2.70 | $3.18 | +2.78% |
| PG | $158.56 | -1.38% | 385.9B | 24.47 | $6.75 | +2.56% |
| UL | $72.01 | -1.67% | 161.8B | 24.02 | $3.08 | +3.10% |
| CL | $93.98 | -1.17% | 78.3B | 36.91 | $2.63 | +2.14% |
| EL | $111.74 | -2.18% | 40.8B | -221.56 | -$0.51 | +1.23% |
| KMB | $108.68 | -0.31% | 36.7B | 22.74 | $4.86 | +4.57% |
| KVUE | $18.66 | -0.32% | 36.3B | 24.94 | $0.76 | +4.37% |
| CHD | $103.25 | +0.16% | 25.3B | 34.85 | $3.02 | +1.13% |
| SGI | $89.45 | -1.92% | 18.3B | 55.43 | $1.57 | +0.69% |
| CLX | $122.22 | -1.12% | 15.5B | 20.75 | $6.11 | +3.90% |
Stock Comparison
NUS vs PG Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, PG has a market cap of 385.9B. Regarding current trading prices, NUS is priced at $8.66, while PG trades at $158.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas PG's P/E ratio is 24.47. In terms of profitability, NUS's ROE is +0.20%, compared to PG's ROE of +0.31%. Regarding short-term risk, NUS is more volatile compared to PG. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check PG's competition here
NUS vs UL Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, UL has a market cap of 161.8B. Regarding current trading prices, NUS is priced at $8.66, while UL trades at $72.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas UL's P/E ratio is 24.02. In terms of profitability, NUS's ROE is +0.20%, compared to UL's ROE of +0.36%. Regarding short-term risk, NUS is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check UL's competition here
NUS vs CL Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, CL has a market cap of 78.3B. Regarding current trading prices, NUS is priced at $8.66, while CL trades at $93.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas CL's P/E ratio is 36.91. In terms of profitability, NUS's ROE is +0.20%, compared to CL's ROE of +4.32%. Regarding short-term risk, NUS is more volatile compared to CL. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check CL's competition here
NUS vs EL Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, EL has a market cap of 40.8B. Regarding current trading prices, NUS is priced at $8.66, while EL trades at $111.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas EL's P/E ratio is -221.56. In terms of profitability, NUS's ROE is +0.20%, compared to EL's ROE of -0.04%. Regarding short-term risk, NUS is more volatile compared to EL. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check EL's competition here
NUS vs KMB Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, KMB has a market cap of 36.7B. Regarding current trading prices, NUS is priced at $8.66, while KMB trades at $108.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas KMB's P/E ratio is 22.74. In terms of profitability, NUS's ROE is +0.20%, compared to KMB's ROE of +1.55%. Regarding short-term risk, NUS is more volatile compared to KMB. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check KMB's competition here
NUS vs KVUE Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, KVUE has a market cap of 36.3B. Regarding current trading prices, NUS is priced at $8.66, while KVUE trades at $18.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas KVUE's P/E ratio is 24.94. In terms of profitability, NUS's ROE is +0.20%, compared to KVUE's ROE of +0.14%. Regarding short-term risk, NUS is more volatile compared to KVUE. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check KVUE's competition here
NUS vs CHD Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, CHD has a market cap of 25.3B. Regarding current trading prices, NUS is priced at $8.66, while CHD trades at $103.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas CHD's P/E ratio is 34.85. In terms of profitability, NUS's ROE is +0.20%, compared to CHD's ROE of +0.17%. Regarding short-term risk, NUS is more volatile compared to CHD. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check CHD's competition here
NUS vs SGI Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, SGI has a market cap of 18.3B. Regarding current trading prices, NUS is priced at $8.66, while SGI trades at $89.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas SGI's P/E ratio is 55.43. In terms of profitability, NUS's ROE is +0.20%, compared to SGI's ROE of +0.13%. Regarding short-term risk, NUS is more volatile compared to SGI. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check SGI's competition here
NUS vs CLX Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, CLX has a market cap of 15.5B. Regarding current trading prices, NUS is priced at $8.66, while CLX trades at $122.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas CLX's P/E ratio is 20.75. In terms of profitability, NUS's ROE is +0.20%, compared to CLX's ROE of +15.02%. Regarding short-term risk, NUS is more volatile compared to CLX. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check CLX's competition here
NUS vs ELF Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, ELF has a market cap of 5.4B. Regarding current trading prices, NUS is priced at $8.66, while ELF trades at $91.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas ELF's P/E ratio is 50.88. In terms of profitability, NUS's ROE is +0.20%, compared to ELF's ROE of +0.11%. Regarding short-term risk, NUS is less volatile compared to ELF. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check ELF's competition here
NUS vs NTCO Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, NUS is priced at $8.66, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas NTCO's P/E ratio is -11.37. In terms of profitability, NUS's ROE is +0.20%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, NUS is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check NTCO's competition here
NUS vs IPAR Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, IPAR has a market cap of 3.3B. Regarding current trading prices, NUS is priced at $8.66, while IPAR trades at $101.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas IPAR's P/E ratio is 19.82. In terms of profitability, NUS's ROE is +0.20%, compared to IPAR's ROE of +0.20%. Regarding short-term risk, NUS is more volatile compared to IPAR. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check IPAR's competition here
NUS vs COTY Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, COTY has a market cap of 2.3B. Regarding current trading prices, NUS is priced at $8.66, while COTY trades at $2.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas COTY's P/E ratio is -4.19. In terms of profitability, NUS's ROE is +0.20%, compared to COTY's ROE of -0.14%. Regarding short-term risk, NUS is more volatile compared to COTY. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check COTY's competition here
NUS vs NWL Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, NWL has a market cap of 1.9B. Regarding current trading prices, NUS is priced at $8.66, while NWL trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas NWL's P/E ratio is -6.82. In terms of profitability, NUS's ROE is +0.20%, compared to NWL's ROE of -0.11%. Regarding short-term risk, NUS is more volatile compared to NWL. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check NWL's competition here
NUS vs SPB Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, SPB has a market cap of 1.8B. Regarding current trading prices, NUS is priced at $8.66, while SPB trades at $78.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas SPB's P/E ratio is 18.65. In terms of profitability, NUS's ROE is +0.20%, compared to SPB's ROE of +0.06%. Regarding short-term risk, NUS is more volatile compared to SPB. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check SPB's competition here
NUS vs EPC Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, EPC has a market cap of 1B. Regarding current trading prices, NUS is priced at $8.66, while EPC trades at $22.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas EPC's P/E ratio is 203.18. In terms of profitability, NUS's ROE is +0.20%, compared to EPC's ROE of -0.02%. Regarding short-term risk, NUS is more volatile compared to EPC. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check EPC's competition here
NUS vs HELE Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, HELE has a market cap of 401.2M. Regarding current trading prices, NUS is priced at $8.66, while HELE trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas HELE's P/E ratio is -0.50. In terms of profitability, NUS's ROE is +0.20%, compared to HELE's ROE of -0.68%. Regarding short-term risk, NUS is less volatile compared to HELE. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check HELE's competition here
NUS vs EWCZ Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, EWCZ has a market cap of 312.3M. Regarding current trading prices, NUS is priced at $8.66, while EWCZ trades at $5.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas EWCZ's P/E ratio is 21.96. In terms of profitability, NUS's ROE is +0.20%, compared to EWCZ's ROE of +0.16%. Regarding short-term risk, NUS is more volatile compared to EWCZ. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check EWCZ's competition here
NUS vs PTNM Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, NUS is priced at $8.66, while PTNM trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas PTNM's P/E ratio is 346.33. In terms of profitability, NUS's ROE is +0.20%, compared to PTNM's ROE of -0.05%. Regarding short-term risk, NUS is more volatile compared to PTNM. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check PTNM's competition here
NUS vs ACU Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, ACU has a market cap of 168.1M. Regarding current trading prices, NUS is priced at $8.66, while ACU trades at $43.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas ACU's P/E ratio is 18.02. In terms of profitability, NUS's ROE is +0.20%, compared to ACU's ROE of +0.09%. Regarding short-term risk, NUS is more volatile compared to ACU. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check ACU's competition here
NUS vs SKIN Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, SKIN has a market cap of 116.3M. Regarding current trading prices, NUS is priced at $8.66, while SKIN trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas SKIN's P/E ratio is -5.70. In terms of profitability, NUS's ROE is +0.20%, compared to SKIN's ROE of -0.20%. Regarding short-term risk, NUS is less volatile compared to SKIN. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check SKIN's competition here
NUS vs SLSN Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, SLSN has a market cap of 83.2M. Regarding current trading prices, NUS is priced at $8.66, while SLSN trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas SLSN's P/E ratio is 117.99. In terms of profitability, NUS's ROE is +0.20%, compared to SLSN's ROE of +0.07%. Regarding short-term risk, NUS is less volatile compared to SLSN. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check SLSN's competition here
NUS vs GROV Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, GROV has a market cap of 59.2M. Regarding current trading prices, NUS is priced at $8.66, while GROV trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas GROV's P/E ratio is -2.23. In terms of profitability, NUS's ROE is +0.20%, compared to GROV's ROE of -1.87%. Regarding short-term risk, NUS is less volatile compared to GROV. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check GROV's competition here
NUS vs AXIL Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, AXIL has a market cap of 39.5M. Regarding current trading prices, NUS is priced at $8.66, while AXIL trades at $5.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas AXIL's P/E ratio is 34.18. In terms of profitability, NUS's ROE is +0.20%, compared to AXIL's ROE of +0.14%. Regarding short-term risk, NUS is less volatile compared to AXIL. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check AXIL's competition here
NUS vs UG Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, UG has a market cap of 30M. Regarding current trading prices, NUS is priced at $8.66, while UG trades at $6.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas UG's P/E ratio is 15.21. In terms of profitability, NUS's ROE is +0.20%, compared to UG's ROE of +0.18%. Regarding short-term risk, NUS is more volatile compared to UG. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check UG's competition here
NUS vs DSY Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, DSY has a market cap of 14.3M. Regarding current trading prices, NUS is priced at $8.66, while DSY trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas DSY's P/E ratio is -0.38. In terms of profitability, NUS's ROE is +0.20%, compared to DSY's ROE of +14.77%. Regarding short-term risk, NUS is less volatile compared to DSY. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check DSY's competition here
NUS vs MTEX Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, MTEX has a market cap of 13.3M. Regarding current trading prices, NUS is priced at $8.66, while MTEX trades at $7.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas MTEX's P/E ratio is -8.14. In terms of profitability, NUS's ROE is +0.20%, compared to MTEX's ROE of -0.23%. Regarding short-term risk, NUS is more volatile compared to MTEX. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check MTEX's competition here
NUS vs RAY Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, RAY has a market cap of 10.7M. Regarding current trading prices, NUS is priced at $8.66, while RAY trades at $4.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas RAY's P/E ratio is 5.23. In terms of profitability, NUS's ROE is +0.20%, compared to RAY's ROE of +0.09%. Regarding short-term risk, NUS is less volatile compared to RAY. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check RAY's competition here
NUS vs PHH Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, PHH has a market cap of 10M. Regarding current trading prices, NUS is priced at $8.66, while PHH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas PHH's P/E ratio is -0.53. In terms of profitability, NUS's ROE is +0.20%, compared to PHH's ROE of +0.38%. Regarding short-term risk, NUS is less volatile compared to PHH. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check PHH's competition here
NUS vs BRSH Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, NUS is priced at $8.66, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas BRSH's P/E ratio is -0.01. In terms of profitability, NUS's ROE is +0.20%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, NUS is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check BRSH's competition here
NUS vs TANH Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, TANH has a market cap of 5.9M. Regarding current trading prices, NUS is priced at $8.66, while TANH trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas TANH's P/E ratio is -0.08. In terms of profitability, NUS's ROE is +0.20%, compared to TANH's ROE of +0.04%. Regarding short-term risk, NUS is less volatile compared to TANH. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check TANH's competition here
NUS vs TKLF Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, TKLF has a market cap of 1.2M. Regarding current trading prices, NUS is priced at $8.66, while TKLF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas TKLF's P/E ratio is 2.64. In terms of profitability, NUS's ROE is +0.20%, compared to TKLF's ROE of +0.16%. Regarding short-term risk, NUS is less volatile compared to TKLF. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check TKLF's competition here
NUS vs BRSHW Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, NUS is priced at $8.66, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas BRSHW's P/E ratio is N/A. In terms of profitability, NUS's ROE is +0.20%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, NUS is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check BRSHW's competition here
NUS vs SUMR Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, NUS is priced at $8.66, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas SUMR's P/E ratio is -3.66. In terms of profitability, NUS's ROE is +0.20%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, NUS is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check SUMR's competition here
NUS vs REV Comparison February 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 412.7M. In comparison, REV has a market cap of 0. Regarding current trading prices, NUS is priced at $8.66, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 2.70, whereas REV's P/E ratio is -1.19. In terms of profitability, NUS's ROE is +0.20%, compared to REV's ROE of +0.89%. Regarding short-term risk, NUS is less volatile compared to REV. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check REV's competition here